The death of 30-year-old Escarlen De los Santos has brought sharp focus to the volatile intersection of youth culture, social media influence and largely unregulated nicotine delivery systems. In her final days in Los Hatillos, Dominican Republic, De los Santos used her platform to issue a stark warning to her followers, documenting her rapid decline into respiratory failure. Her experience now sits at the centre of a widening debate over how governments regulate vaping and hookah products marketed to young adults.
As her health deteriorated, De los Santos filmed several videos that became viral warnings across Latin America. In one of her final recordings, she pleaded with her generation to abandon the habit she claimed was “destroying her from the inside”. She urged her followers to “look at me now” as she faced the final stages of severe pulmonary complications, transforming a highly personal tragedy into a public reckoning over the risks of these devices.
Respiratory Failure and Emerging Health Clusters
Medical professionals in the Dominican Republic have linked De los Santos’ respiratory collapse to the chronic use of vapes and hookahs. The urgency of the situation is compounded by the fact that her passing follows the death of 22-year-old Frank Sosa in the same municipality. The occurrence of two such severe outcomes in a single area has prompted local clinicians to treat the cases as a potential public health cluster, intensifying scrutiny of how vaping liquids are sourced, mixed and sold in the region.
The progression of these injuries often involves acute inflammation of the lung tissue, which can lead to permanent scarring or total organ failure. In her final moments, De los Santos stated: “Leave that stuff alone, look at me now. I don’t want anyone else to go through this physical torment.”
Doctors warn that the systemic risks associated with these products are often magnified by a lack of transparency regarding ingredients and the absence of standardized manufacturing protocols. In many low- and middle-income countries, enforcement of quality controls remains patchy, leaving young consumers exposed to chemical formulations that may bear little resemblance to those evaluated by regulators.
| Risk Factor | Public Health Impact |
|---|---|
| Unregulated Additives | Increased risk of acute lung injury (EVALI) and other toxic reactions due to unknown chemical contaminants. |
| Nicotine Dependency | High addiction rates in youth, driving sustained use and elevating long-term cardiovascular and respiratory strain. |
| Regulatory Gaps | Insufficient age verification, incomplete product registration and limited enforcement of health warnings on packaging. |
| Grey Market Distribution | Proliferation of counterfeit or modified devices with inconsistent voltage, heating elements and filling practices. |
Global Trends in Vaping-Related Morbidity
While the cases in the Dominican Republic highlight regional vulnerabilities, the severity of vaping-related illness is a global phenomenon. In Manchester, UK, 22-year-old retail assistant Kayley Boda is facing a terminal prognosis after her own addiction to vaping. Boda, who was using one 600-puff device per week, began coughing up a brown, grainy substance in January 2025, leading to a diagnosis that has left her with approximately 18 months to live.
Boda’s case illustrates the aggressive nature of some of these respiratory complications, requiring extreme interventions including the surgical removal of half of her right lung. Reflecting on her experience, she said: “Before the diagnosis, I was very naive and thought that something like this would never happen to me. I had surgery to remove half of my right lung and after the surgery, I started chemo and I had a terrible reaction to it. I couldn’t lift my head up, I was throwing up blood, I was urinating blood.”
Public health agencies in Europe and North America have spent the past decade tracking clusters of vaping-associated lung injury, often referred to as EVALI, while struggling to keep pace with rapidly evolving devices, high-nicotine disposable products and aggressive digital marketing. The pattern emerging from these cases points to a shared challenge: regulators are frequently reacting to harms after they appear in emergency wards rather than pre-empting them through tighter product controls.
Institutional Oversight and Regulatory Pressures
The deaths and critical illnesses of young adults have placed the Dominican Ministry of Public Health under intense scrutiny. Community leaders and medical associations are calling for an immediate overhaul of how nicotine delivery systems are licensed, monitored and sold within the country. The current lack of oversight allows products to enter the market without rigorous safety testing or clear warnings regarding pulmonary risks, even as youth uptake accelerates.
Dominican authorities are also under growing pressure to align national rules with international standards such as the WHO Framework Convention on Tobacco Control, which encourages tighter regulation of novel nicotine and tobacco products. Health lawyers argue that applying these obligations more robustly to vaping could give regulators stronger legal tools to control advertising, restrict flavours attractive to minors and demand full disclosure of ingredients.
To mitigate further loss of life, public health experts emphasize the need for a multi-pronged regulatory approach that goes beyond individual behaviour change and addresses the systems that bring these devices to market:
- Stricter Age Controls: Implementation of rigorous, auditable age-verification systems at both physical and online points of sale, with penalties for non-compliance.
- Mandatory Health Labeling: Requirement for prominent, standardized warnings detailing the risk of respiratory failure and addiction on all devices and refill containers.
- Ingredient Transparency: Legislative mandates requiring manufacturers and importers to disclose and register all chemical components of e-liquids before sale.
- Enhanced Surveillance: Establishment of a real-time reporting system for hospitals and clinics to flag suspected vaping-related lung injuries to national public health officials.
The transition from casual use to systemic organ failure, as seen in these cases, underscores the volatility of these devices when left to underregulated markets. As regulatory frameworks struggle to keep pace with the rapid evolution of the vaping industry, the burden of risk continues to fall on young populations, often resulting in irreversible respiratory damage and premature death.
For families in Los Hatillos and Manchester, the policy debate has already arrived too late. But the voices of De los Santos and Boda – recorded from hospital beds and shared millions of times – have become a catalyst for a broader question facing health ministries worldwide: whether existing tobacco-control rules are enough to confront a new generation of nicotine products that are reshaping youth culture at a speed regulators have yet to match.
Worth a look


